3 results
Approved WMOWill not start
T\o evaluate the pharmacokinetics, safety and tolerability of the research medication
Approved WMOWill not start
The primary objective for this study is to compare the safety, tolerability and analgesic efficacy of ABT-110 administered subcutaneously (SC) once every 8 weeks (q8w) for a total of 2 doses to placebo in subjects with pain due to osteoarthritis (OA…
Approved WMOCompleted
To compare skin condition for monitoring with the Bambi Belt versus skin condition with routine monitoring.